The present invention concerns a cosmetic method for dyeing or making up keratin fibres, in particular eyelashes and/or eyebrows and preferably eyebrows, comprising the application, to the keratin fibres, of at least: a) A dyeing cosmetic composition A comprising, in a physiologically acceptable medium, one or more natural dye(s) chosen from the group consisting of neoflavonoids, gallic tannins and catechic tannins, and/or proanthocyanidins and the derivatives of same and the mixtures thereof, or preferably one or more plant extracts containing same, and advantageously an antioxidant, b) A revealing cosmetic composition B comprising, in a physiologically acceptable medium, at least one iron salt and/or one aluminium salt, in particular an iron gluconate or an iron sulphate, composition A being applied before or after composition B, and preferably before composition B.

A reductive composition, suitable for the dental industry, which utilizes sodium dithionite may be provided when it is combined with a sweetener selected from the salts of acesulfame. Sodium and potassium acesulfame show effective resistance to the reductive capacity of sodium dithionite. Other dithionite molecules, such as potassium dithionite, may be used.

A reductive composition, suitable for the dental industry, which utilizes sodium dithionite may be provided when it is combined with a sweetener selected from the salts of acesulfame. Sodium and potassium acesulfame show effective resistance to the reductive capacity of sodium dithionite. Other dithionite molecules, such as potassium dithionite, may be used.

A method for reversing or mitigating skin aging comprising topically applying a composition which comprises at least one oxidant, and at least one fluorescent dye capable of activating the oxidant and illuminating said composition for a time sufficient to activate the at least one oxidant.

A non-irritation, non-blurring, photostable ophthalmic sunscreen composition contains at least one of the following: bemotrizinol; bisoctrizole; tris-biphenyl triazine; and/or octyl methoxycinnamate. A liquid vehicle base is then a remainder of the solution by weight. The composition is an artificial tear formulation or an ophthalmic suspension or ointment. The composition may include at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule.

The present invention provides compounds as PPAR agonists and their application, involving a new class of peroxisome proliferator-activated receptor (PPAR) gamma receptor agonist, which can inhibit the production of mitochondrial reactive oxygen species, and most of which can readily cross the blood-brain barrier. The present invention also includes pharmaceutical uses of the compounds.

An aqueous personal care composition comprising: one or more amphoacetates; one or more glutamate surfactants selected from sodium lauroyl glutamate, dipotassium cocoyl glutamate, potassium lauryl/myristoyl glutamate and combinations thereof; and cocamide MIPA; wherein the composition is free of sulfates and ethoxylates.

An aqueous personal care composition comprising: one or more amphoacetates; one or more glutamate surfactants selected from sodium lauroyl glutamate, dipotassium cocoyl glutamate, potassium lauryl/myristoyl glutamate and combinations thereof; and cocamide MIPA; wherein the composition is free of sulfates and ethoxylates.

A composition for stimulating facial hair growth includes a vasodilator including a medication that stimulates cell proliferation of a plurality of facial follicles of an individual, an additive, and a delivery carrier designed to be applied to the individual, wherein the delivery carrier is further configured to enhance stability of the vasodilator and the additive.

The present invention relates to a nanoemulsion comprising at least one aqueous component and a carrier, wherein the carrier comprises at least one lipophilic component, at least one surfactant and at least one alcohol. The present invention further relates to a composition comprising said nanoemulsion and an active agent. In particular, the composition is present as a gel and the active agent is 5-aminolevulinic acid, a derivative, precursor and/or metabolite thereof. The invention further relates to the preparation of said nanoemulsion and/or composition and to their use for the treatment of dermatological diseases, virus-associated diseases as well as diseases associated with cell proliferation, in particular, tumor diseases and/or psoriasis. The present invention is further directed to the use of said nanoemulsion in cosmetics.